1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising incidence of chronic respiratory diseases globally
5.2.2. Surge in use of development of digital or smart inhalers
5.2.3. Increasing shift toward pulmonary drug delivery devices as alternate route
5.3. Restraints
5.3.1. Issues concerned with price and regulations
5.4. Opportunities
5.4.1. Emerging technological advancements in pulmonary devices
5.4.2. Increasing healthcare expenditure on therapeutic devices
5.5. Challenges
5.5.1. Difficulty in maintenance due to deposition of aerosolized particles

6. Pulmonary Drug Delivery Devices Market, by Product Type
6.1. Introduction
6.2. Dry Powder Inhaler
6.3. Metered Dose Inhaler
6.4. Nebulizer

7. Pulmonary Drug Delivery Devices Market, by Application
7.1. Introduction
7.2. Asthma
7.3. COPD
7.4. Cystic Fibrosis

8. Pulmonary Drug Delivery Devices Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacy Stores

9. Americas Pulmonary Drug Delivery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pulmonary Drug Delivery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Aerogen
13.2. AstraZeneca Plc
13.3. Boehringer Ingelheim Gmbh
13.4. Briggs Healthcare, Inc.
13.5. Celares GmbH
13.6. Cipla Inc
13.7. GF Health Products, Inc.
13.8. Gilbert Technologies
13.9. GlaxoSmithKline Plc
13.10. Jabil Inc
13.11. Koninklijke Philips N.V.
13.12. MannKind Corporation
13.13. Merck & Co., Inc.
13.14. Mylan N.V.
13.15. Novartis AG
13.16. Omron Corporation
13.17. Sunovion Pharmaceuticals Inc.
13.18. The 3M Company

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2026
FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2026
FIGURE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 23. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 25. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 30. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 31. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 32. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 33. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 34. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 35. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 36. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 16. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 17. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SCORES
TABLE 46. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: BUSINESS STRATEGY
TABLE 47. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: PRODUCT SATISFACTION
TABLE 48. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: RANKING
TABLE 49. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 50. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: MERGER & ACQUISITION
TABLE 51. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 52. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 53. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: INVESTMENT & FUNDING
TABLE 54. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 55. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

Aerogen
AstraZeneca Plc
Boehringer Ingelheim Gmbh
Briggs Healthcare, Inc.
Celares GmbH
Cipla Inc
GF Health Products, Inc.
Gilbert Technologies
GlaxoSmithKline Plc
Jabil Inc
Koninklijke Philips N.V.
MannKind Corporation
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Omron Corporation
Sunovion Pharmaceuticals Inc.
The 3M Company